A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of Selnoflast in Participants with Moderate to Severe Asthma

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504304-29-00

Acronym

BP44551

Enrollment

Registered

2024-01-22

Start date

2024-03-01

Completion date

2025-11-13

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moderate to Severe Asthma

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Germany, Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026